Current experimental disease-modifying therapeutics for multiple system atrophy

Multiple system atrophy (MSA) is a challenging neurodegenerative disorder with a difficult and often inaccurate early diagnosis, still lacking effective treatment. It is characterized by a highly variable clinical presentation with parkinsonism, cerebellar ataxia, autonomic dysfunction, and pyramida...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemos, Miguel, Wenning, Gregor K., Stefanova, Nadia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2021
Materias:
Neurology and Preclinical Neurological Studies - Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528757/
https://www.ncbi.nlm.nih.gov/pubmed/34398313
http://dx.doi.org/10.1007/s00702-021-02406-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528757/
https://www.ncbi.nlm.nih.gov/pubmed/34398313
http://dx.doi.org/10.1007/s00702-021-02406-z

Ejemplares similares